News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Features Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question L.A. McKeown August 09, 2024
News Features FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs Yael L. Maxwell December 14, 2023
News Features THT 2023 The Promise of AI for Improving Health Equity in Heart Failure Todd Neale April 04, 2023
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Features Bloodlines: How Far Should Cardiologists Go in Treating Family? Todd Neale March 10, 2022
News Features Expired Cardiac Devices May Do Global Good, but Safety Unknown Yael L. Maxwell August 26, 2021
News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Features Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019 L.A. McKeown December 12, 2019
News Features Subtherapeutic Heparin: As Stories Multiply, Concerns Mount Yael L. Maxwell November 27, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Features Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen? Michael O'Riordan September 13, 2017
News Features A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease Yael L. Maxwell August 02, 2017
News Features Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions? Todd Neale June 21, 2017